Inventera Inc.

Inventera Inc. is a biotechnology company that develops MRI contrast agents. It offers nanoparticle-based platforms designed to improve both the resolution and safety of MRI. Its contrast agents target the articular system, lymphatic vessels, and the pancreatic and biliary systems. The company was incorporated in 2018 and is based in Seoul, South Korea.